Electra Therapeutics Appoints Graham Parry as Chief Scientific Officer and Kim-Hien Dao as Chief Medical Officer
Position
Chief Medical Officer
Company
Electra Therapeutics
South San FranciscoManufacturingBiotechnologySustainabilityHealth CareScience And EngineeringMiningDescription
Electra Therapeutics, Inc. announced the appointment of Graham Parry, PhD, as Chief Scientific Officer and Kim-Hien Dao, DO, PhD, as Chief Medical Officer. Both executives have deep experience in drug development and each have been instrumental in leading multiple drug candidates through clinical trials and toward regulatory approval.
Quick answer
Electra Therapeutics Appoints Graham Parry as Chief Scientific Officer and Kim-Hien Dao as Chief Medical Officer (June 3, 2024). Electra Therapeutics is based in South San Francisco, California, United States.
- Who is the new Chief Medical Officer at Electra Therapeutics?
- Electra Therapeutics named Kim-Hien Dao Chief Medical Officer, announced June 3, 2024.
- What did Electra Therapeutics announce on June 3, 2024?
- Electra Therapeutics, Inc. announced the appointment of Graham Parry, PhD, as Chief Scientific Officer and Kim-Hien Dao, DO, PhD, as Chief Medical Officer. Both executives have deep experience in drug development and each have been instrumental in leading multiple drug candidates through clinical trials and toward regulatory approval.
- What does Electra Therapeutics do?
- Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
- Where is Electra Therapeutics based?
- Electra Therapeutics is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Contineum Therapeutics (June 3, 2024), Eli Lilly and Company (June 4, 2024), Danaher (June 5, 2024) and Nucleus RadioPharma (June 5, 2024) also announced leadership changes within 45 days of Electra Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Sustainability and Science And Engineering
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
- Eli Lilly and Company Appoints Melissa Seymour as Executive Vice President of Global Quality (June 4, 2024)
- Danaher Corporation Appoints Dr. Martin Stumpe as Chief Data & Artificial Intelligence (AI) Officer (June 5, 2024)
- Nucleus RadioPharma Appoints Tyrell Rivers as Executive Director of Corporate Ventures (June 5, 2024)
- Allurion Technologies, Inc. Appoints Ojas A. Buch as Chief Operating Officer (June 5, 2024)
- Neurovalens Appoints Kate Willis as Vice President of Commercialization (June 5, 2024)
Who to call at Electra Therapeutics, and when
A new leader at Electra Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Electra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Electra Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Electra Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.